"Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis." A. Campredon, E. Battistella, C. Martin, et al. Eur Respir J 2022; 59: 2101344
- PMID: 36997234
- DOI: 10.1183/13993003.51344-2021
"Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis." A. Campredon, E. Battistella, C. Martin, et al. Eur Respir J 2022; 59: 2101344
Erratum for
-
Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis.Eur Respir J. 2022 Jun 16;59(6):2101344. doi: 10.1183/13993003.01344-2021. Print 2022 Jun. Eur Respir J. 2022. PMID: 34795038
Publication types
LinkOut - more resources
Full Text Sources